Source: Massachusetts Newswire

C Diff Foundation: The C Diff Foundation Assures U.S. Patients C. diff. Clinical Trials Continue to Move Forward Safely

TAMPA, Fla., Jan. 11, 2021 (SEND2PRESS NEWSWIRE) -- While some patients diagnosed with Clostridioides difficile (C. diff., C. difficile, CDI) believe they have run into clinical trial roadblocks, due to the recent focus on the pandemic, the C Diff Foundation wants them to know they are not out of options. Safe and active clinical trials continue. The post The C Diff Foundation Assures U.S. Patients C. diff. Clinical Trials Continue to Move Forward Safely appeared first on Massachusetts Newswire.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



C Diff Foundation is a Private company. C Diff Foundation generates $87.1K in revenue per employee C Diff Foundation has 3 followers on Owler.